Gastro-oesophageal Reflux Disease Trial, Recruiting (NCT00260585)

Gastro-oesophageal Reflux Disease Trial, Recruiting NCT00260585 Sponsor: University of Pittsburgh Condition: Gastro-oesophageal Reflux Disease

Printed from Voxsanity (voxsanity.com.au) — NCT00260585 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Gord

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have a known or suspected cancer in the food pipe (esophagus) or where the food pipe meets the stomach
You have been diagnosed with a condition called Barrett's metaplasia, where cells in the food pipe change in an abnormal way
You are being treated for symptoms of acid reflux (also known as GERD), where stomach acid regularly flows back into the food pipe
You have a condition called achalasia, where the food pipe has difficulty moving food down to the stomach
You have a hiatal hernia, where part of the stomach pushes up through the diaphragm into the chest

Who may not be able to join:

If your pre-surgery blood test results are outside of normal ranges, you will not be able to have the additional tissue samples (biopsies) taken as part of this trial (confirm with trial site)
If your blood clotting levels are outside of safe limits — specifically a platelet count below 150,000, a PTT score of 50 or above, or an INR score of 1.8 or above — you will not be able to have the additional tissue samples taken

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 26 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: James D. Luketich, MD, Department of Cardiothoracic Surgery

Phone: 412-647-8583

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT00260585

Sponsor: University of Pittsburgh

Phase: Not Applicable

Status: Recruiting

Condition: Gastro-oesophageal Reflux Disease

Trial contact: 412-647-8583

More information: https://clinicaltrials.gov/study/NCT00260585

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have a known or suspected cancer in the food pipe (esophagus) or where the food pipe meets the stomach
You have been diagnosed with a condition called Barrett's metaplasia, where cells in the food pipe change in an abnormal way
You are being treated for symptoms of acid reflux (also known as GERD), where stomach acid regularly flows back into the food pipe
You have a condition called achalasia, where the food pipe has difficulty moving food down to the stomach
You have a hiatal hernia, where part of the stomach pushes up through the diaphragm into the chest

Who may not be able to join:

If your pre-surgery blood test results are outside of normal ranges, you will not be able to have the additional tissue samples (biopsies) taken as part of this trial (confirm with trial site)
If your blood clotting levels are outside of safe limits — specifically a platelet count below 150,000, a PTT score of 50 or above, or an INR score of 1.8 or above — you will not be able to have the additional tissue samples taken

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 26 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

University of Pittsburgh

Registry

ClinicalTrials.gov

Start date

1 June 1999

Est. completion

1 December 2050

Where this trial is recruiting

🇺🇸 United States

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov